13F

SBC SBC MEDICAL GROUP HOLDINGS I

2026Q1 · CUSIP 73245B107 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
48
Δ holders QoQ
+6
Breadth percentile
Top 39%
Whale holders
27
Δ whales
+4
Inst. holding value
$6M
New positions
10
Closed positions
4
Price momentum (1Q)
Put / Call
0/0

Breadth history (34 quarters)

2022Q4: Δ+24 · h=46 2023Q1: Δ-7 · h=39 2023Q2: Δ-25 · h=14 2023Q3: Δ+0 · h=14 2023Q4: Δ+2 · h=16 2024Q1: Δ-10 · h=6 2024Q2: Δ+0 · h=6 2024Q3: Δ-2 · h=4 2024Q4: Δ+2 · h=6 2025Q1: Δ-1 · h=5 2025Q2: Δ+25 · h=30 2025Q3: Δ+12 · h=42 2025Q4: Δ+0 · h=42 2026Q1: Δ+6 · h=48 2022Q4: holders=46 2023Q1: holders=39 2023Q2: holders=14 2023Q3: holders=14 2023Q4: holders=16 2024Q1: holders=6 2024Q2: holders=6 2024Q3: holders=4 2024Q4: holders=6 2025Q1: holders=5 2025Q2: holders=30 2025Q3: holders=42 2025Q4: holders=42 2026Q1: holders=48 -25 -12.5 +0 +12.5 +25 32751 22Q423Q123Q223Q323Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q2 Top 12%
2022Q4 Top 16% -1.7% +1.3%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
7.7
EPS (TTM)
$0.40
EPS YoY
-18.4%
Revenue (TTM)
$0.2B
Revenue YoY
-14.4%
Quarterly Revenue & EPS (4Y)
2023-09-30: $47M 2024-03-31: $55M 2024-06-30: $53M 2024-09-30: $53M 2024-12-31: $44M 2025-03-31: $47M 2025-06-30: $43M 2025-09-30: $43M 2025-12-31: $40M 2026-03-31: $43M 2023-09-30: EPS 0.09 2024-03-31: EPS 0.20 2024-06-30: EPS 0.20 2024-09-30: EPS 0.03 2024-12-31: EPS 0.05 2025-03-31: EPS 0.21 2025-06-30: EPS 0.02 2025-09-30: EPS 0.12 2025-12-31: EPS 0.15 2026-03-31: EPS 0.11 0M 27M 55M $M 0.00 0.12 0.23 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 9 2024-09-30: PE 13.32024-12-31: PE 102025-03-31: PE 6.92025-06-30: PE 14.42025-09-30: PE 8.32025-12-31: PE 9.32026-03-31: PE 7.4 6 11 15 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)